Clinical diagnostic and radiographic features of a primary intradural spinal chondrosarcoma in a young adult: illustrative case.

intradural extramedullary mesenchymal chondrosarcoma primary spinal tumors

Journal

Journal of neurosurgery. Case lessons
ISSN: 2694-1902
Titre abrégé: J Neurosurg Case Lessons
Pays: United States
ID NLM: 9918227275606676

Informations de publication

Date de publication:
21 Aug 2023
Historique:
received: 15 06 2023
accepted: 19 07 2023
medline: 20 9 2023
pubmed: 20 9 2023
entrez: 20 9 2023
Statut: epublish

Résumé

Mesenchymal chondrosarcoma (MCS) is an aggressive subtype of chondrosarcoma that occurs extremely rarely in the central nervous system. Patients often present with pain or sensorimotor deficits, and resection is considered the gold standard. The role of adjuvant radiation and/or chemotherapy is largely unknown. A 22-year-old male presented with a 4-month history of progressive back and bilateral leg pain. He underwent imaging workup with magnetic resonance imaging of the lumbar spine and was found to have an intradural, extramedullary, heterogeneously enhancing mass spanning the L4-5 vertebral levels. Intraoperatively, a lobular, partially calcified mass with a ventral dural attachment displacing the nerve roots laterally was observed. The mass was removed en bloc, and the patient later underwent adjuvant radiotherapy, with no evidence of recurrence 2 years following surgery. Spinal MCS is extremely rare and often presents with a more aggressive course than conventional chondrosarcoma. Radiological diagnosis is challenging, as the tumor mimics different pathologies. The presence of calcifications, heterogeneous enhancement, and a more rapid clinical course as well as the presence of HEY1::NCOA2 gene fusion, which can be detected by surrogate immunohistochemistry, aids in diagnosis. Resection is the standard of care, and adjuvant radiation may be considered to reduce local recurrence, although further studies are warranted.

Sections du résumé

BACKGROUND BACKGROUND
Mesenchymal chondrosarcoma (MCS) is an aggressive subtype of chondrosarcoma that occurs extremely rarely in the central nervous system. Patients often present with pain or sensorimotor deficits, and resection is considered the gold standard. The role of adjuvant radiation and/or chemotherapy is largely unknown.
OBSERVATIONS METHODS
A 22-year-old male presented with a 4-month history of progressive back and bilateral leg pain. He underwent imaging workup with magnetic resonance imaging of the lumbar spine and was found to have an intradural, extramedullary, heterogeneously enhancing mass spanning the L4-5 vertebral levels. Intraoperatively, a lobular, partially calcified mass with a ventral dural attachment displacing the nerve roots laterally was observed. The mass was removed en bloc, and the patient later underwent adjuvant radiotherapy, with no evidence of recurrence 2 years following surgery.
LESSONS CONCLUSIONS
Spinal MCS is extremely rare and often presents with a more aggressive course than conventional chondrosarcoma. Radiological diagnosis is challenging, as the tumor mimics different pathologies. The presence of calcifications, heterogeneous enhancement, and a more rapid clinical course as well as the presence of HEY1::NCOA2 gene fusion, which can be detected by surrogate immunohistochemistry, aids in diagnosis. Resection is the standard of care, and adjuvant radiation may be considered to reduce local recurrence, although further studies are warranted.

Identifiants

pubmed: 37728306
doi: 10.3171/CASE23317
pii: CASE23317
pmc: PMC10555558
doi:
pii:

Types de publication

Journal Article

Langues

eng

Références

Oncologist. 2008 Mar;13(3):320-9
pubmed: 18378543
Cancer. 1996 May 1;77(9):1884-91
pubmed: 8646689
Eur J Cancer. 2015 Feb;51(3):374-81
pubmed: 25529371
Oncol Lett. 2014 Oct;8(4):1608-1612
pubmed: 25202377
Arch Pathol Lab Med. 2012 Jan;136(1):61-75
pubmed: 22208489
Spine (Phila Pa 1976). 2017 May 1;42(9):644-652
pubmed: 28441682
J Magn Reson Imaging. 1991 Jan-Feb;1(1):93-5
pubmed: 1802137
Skeletal Radiol. 2005 Dec;34(12):785-92
pubmed: 16211384
Tumori. 2017 Nov 15;103(Suppl. 1):e66-e72
pubmed: 29143958
Pediatr Radiol. 2007 Nov;37(11):1155-8
pubmed: 17849111
Clin Nucl Med. 2014 Jan;39(1):e64-6
pubmed: 23877507
Surg Neurol. 1989 Jan;31(1):54-7
pubmed: 2645674
Radiographics. 2003 Sep-Oct;23(5):1245-78
pubmed: 12975513
Neurol India. 2012 Mar-Apr;60(2):252-4
pubmed: 22626722
Arch Pathol Lab Med. 2018 Nov;142(11):1421-1424
pubmed: 30407856
Cancer. 1986 Jun 15;57(12):2444-53
pubmed: 3697943
Transl Cancer Res. 2022 Sep;11(9):3371-3378
pubmed: 36237254
Surg Neurol Int. 2023 Apr 07;14:128
pubmed: 37151474
World Neurosurg. 2021 Jan;145:376-380
pubmed: 33049384
Cancer. 1983 Apr 1;51(7):1230-7
pubmed: 6825046
BMC Musculoskelet Disord. 2019 Sep 4;20(1):408
pubmed: 31484514
J Neuroradiol. 2008 Jul;35(3):189-91
pubmed: 18243318
PLoS One. 2012;7(11):e49705
pubmed: 23185413
Surg J (N Y). 2017 Jul 20;3(3):e117-e123
pubmed: 28825035
Spine J. 2016 Oct;16(10):e711
pubmed: 27012648
Bosn J Basic Med Sci. 2009 Oct;9 Suppl 1:S40-S45
pubmed: 19912118
Radiology. 1993 Mar;186(3):819-26
pubmed: 8430193
Cancer. 2008 Jun;112(11):2424-31
pubmed: 18438777
J Neurosurg. 1994 May;80(5):928-30
pubmed: 8169637
Cancer. 1978 Dec;42(6):2744-52
pubmed: 365318
J Pediatr Neurosci. 2013 May;8(2):111-2
pubmed: 24082926
F1000Res. 2018 Nov 20;7:
pubmed: 30519452
World J Surg Oncol. 2017 Apr 4;15(1):73
pubmed: 28376922
Transl Cancer Res. 2022 Sep;11(9):3409-3415
pubmed: 36237268
World Neurosurg. 2018 Aug;116:e691-e698
pubmed: 29783007
Case Rep Radiol. 2018 Feb 28;2018:6921020
pubmed: 29682386
Genes Chromosomes Cancer. 2012 Feb;51(2):127-39
pubmed: 22034177
J Surg Oncol. 2016 Dec;114(8):982-986
pubmed: 27790706

Auteurs

Anthony J Piscopo (AJ)

Departments of1Neurosurgery.

Nahom Teferi (N)

Departments of1Neurosurgery.

Alec Hanson (A)

2University of Iowa Carver, College of Medicine, Iowa City, Iowa.

Meron Challa (M)

2University of Iowa Carver, College of Medicine, Iowa City, Iowa.

Mark Smith (M)

3Radiation Oncology, and.

Kathryn Eschbacher (K)

4Pathology, University of Iowa Hospital and Clinics, Iowa City, Iowa; and.

Patrick Hitchon (P)

Departments of1Neurosurgery.

Classifications MeSH